Active Versus Passive Sitting, Cognition and Energy
18 de agosto de 2026 actualizado por: Joseph Signorile, University of Miami
Differences in Muscle Utilization, Tissue Pressure, Cognitive Performance, and Caloric Output Among Active and Passive Sitting Positions.
The study will compare cognitive capacity, muscle utilization patterns, soft tissue seated pressure and caloric output during four seated conditions:
- passive sitting in a regular chair;
- passive sitting in an exercise chair;
- sitting in the exercise chair during active dynamic exercise; and,
- sitting in the chair during active static exercise.
Descripción general del estudio
Estado
Reclutamiento
Condiciones
Intervención / Tratamiento
Tipo de estudio
Intervencionista
Inscripción (Estimado)
35
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: Ethan J Elkins, MS
- Número de teléfono: 3052844173
- Correo electrónico: exe453@miami.edu
Copia de seguridad de contactos de estudio
- Nombre: Joseph Signorile J Joseph Signorile, PhD
- Número de teléfono: 3058981458
- Correo electrónico: jsignorile@miami.edu
Ubicaciones de estudio
-
-
Florida
-
Coral Gables, Florida, Estados Unidos, 33146
- Reclutamiento
- Laboratory of Neuromuscular Research and Active Aging
-
Contacto:
- Ethan J Elkins, MS
- Número de teléfono: 3052844173
- Correo electrónico: exe453@miami.edu
-
Contacto:
- Joseph Signorile Joseph Signorile, PhD
- Número de teléfono: 305-898-1458
- Correo electrónico: jsignorile@miami.edu
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Sí
Descripción
Inclusion Criteria:
- Adult (18-70)
Exclusion Criteria:
- Any current injury in the lower limb or trunk.
- Use of prescription drugs or supplements that may affect cardiovascular or neuromuscular responses.
- Reported lack of sleep or stress that may affect physiological responses to exercise.
- Cardiovascular, respiratory, neurologic, balance, metabolic, or musculoskeletal conditions that could increase risk during exercise testing
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Ciencia básica
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Passive Comparator: Traditional Chair
Participant will sit in the traditional chair for the amount of time it takes them to read a scientific article.
|
|
|
Comparador de placebos: Passive Comparator: Exercise Chair
Participant will sit in the exercise chair for the amount of time it takes them to read a scientific article.
|
A chair-based exercise program using a specialized chair that allows participants to lift their body weight.
|
|
Experimental: Experimental: Dynamic Leg Exercise in Exercise Chair
Participant will sit in the exercise chair for the amount of time it takes them to read a scientific article while actively pushing down and releasing the foot operated lever as many times as possible.
|
A chair-based exercise program performed using a specialized exercise chair equipped with a foot-operated lever.
Participants repeatedly depress and release the foot-operated lever during the intervention period.
|
|
Experimental: Experimental: Static Leg Exercise in Exercise Chair
Participant will sit in the exercise chair for the amount of time it takes them to read a scientific article while actively pushing down and holding the foot operated lever.
|
A chair-based exercise program performed using a specialized exercise chair equipped with a foot-operated lever.
Participants depress and maintain pressure on the foot-operated lever during the intervention period.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Differences in cognitive performance among chair conditions as measured by the Psychomotor Vigilance Test in number of key depressions
Periodo de tiempo: Approximately 3 minutes
|
Cognitive performance will be assessed using the 3-minute Psychomotor Vigilance Test (PVT).
During the test, participants will press the space bar as quickly as possible in response to the appearance of a visual stimulus on a computer screen.
Performance will be measured as the total number of valid responses recorded during the test.
Higher values indicate greater alertness, sustained attention, and reaction speed.
|
Approximately 3 minutes
|
|
Executive function among chair conditions as measured by the Stroop Test using words counted.
Periodo de tiempo: Approximately 5 minutes.
|
Executive function will be assessed using the Stroop Test, a cognitive task requiring participants to respond to color word stimuli.
The outcome will be measured by total words counted, reported as the number of words.
|
Approximately 5 minutes.
|
|
Executive function among chair conditions as measured by the Stroop Test using error rate.
Periodo de tiempo: Approximately 5 minutes.
|
Executive function will be assessed using the Stroop Test, a cognitive task requiring participants to respond to color word stimuli.
The outcome will be measured by error rate, reported as the percentage of errors.
|
Approximately 5 minutes.
|
|
Muscle activity among chair conditions using electromyography
Periodo de tiempo: Approximately 45 minutes
|
Muscle activity will be assessed using surface electromyography (EMG).
Muscle activation will be quantified as EMG amplitude, measured in microvolts (µV) from EMG recordings.
Higher values indicate greater muscle activity.
|
Approximately 45 minutes
|
|
Peak seated tissue pressure among chair conditions using a pressure sensitive mat
Periodo de tiempo: Approximately 15 minutes
|
Seated tissue pressure will be assessed using a pressure-sensitive mat placed on the seat surface of each chair.
Peak pressure will be recorded to quantify the highest pressure exerted at the seating interface during each chair condition, measured in kilopascals.
Higher values indicate greater localized pressure on seated tissues.
|
Approximately 15 minutes
|
|
Metabolic cost of sitting among the chair conditions using a portable oxygen consumption unit
Periodo de tiempo: Approximately 25 minutes
|
Metabolic cost during sitting will be assessed under each chair condition using a portable indirect calorimetry device.
Participants will wear a facemask that measures oxygen consumption (VO₂) and carbon dioxide production (VCO₂).
These measurements will be used to estimate energy expenditure during the sitting period.
Higher values indicate greater metabolic cost.
|
Approximately 25 minutes
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Joseph J Signorile, PhD, University of Miami - Coral Gables Campus
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
23 de junio de 2026
Finalización primaria (Estimado)
30 de septiembre de 2027
Finalización del estudio (Estimado)
30 de septiembre de 2027
Fechas de registro del estudio
Enviado por primera vez
7 de julio de 2026
Primero enviado que cumplió con los criterios de control de calidad
7 de julio de 2026
Publicado por primera vez (Actual)
13 de julio de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
20 de agosto de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
18 de agosto de 2026
Última verificación
1 de agosto de 2026
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- 20260691
- FP00021633 (Otro número de subvención/financiamiento: Robot Studios)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .